• Je něco špatně v tomto záznamu ?

Oligodendroglial response in the spinal cord in TDP-43 proteinopathy with motor neuron involvement

Z. Rohan, R. Matej, R. Rusina, GG. Kovacs,

. 2014 ; 14 (3) : 117-124. [pub] 20140805

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031911

Grantová podpora
NT12094 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 2004-04-01 do 2015-11-30
Medline Complete (EBSCOhost) od 2005-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2004-04-01 do 2015-11-30
Health & Medicine (ProQuest) od 2004-04-01 do 2015-11-30
Family Health Database (ProQuest) od 2004-04-01 do 2015-11-30
Psychology Database (ProQuest) od 2004-04-01 do 2015-11-30

BACKGROUND: TDP-43 proteinopathies represent a spectrum of neurodegenerative disorders. Variable clinical presentations including frontotemporal dementia, amyotrophic lateral sclerosis (ALS) and mixed forms are associated with the spatial heterogeneity of the TDP-43 pathology. Recent studies have emphasized the role of oligodendrocytes in the pathogenesis of ALS. OBJECTIVE: To evaluate whether TDP-43 proteinopathies are associated with an oligodendroglial response. METHODS: We performed a study on 7 controls and 10 diseased patients with spinal cord involvement. Using the oligodendroglia-specific antibody TPPP/p25, we assessed oligodendrocyte density in the lateral corticospinal tracts (LCSs) along with the presence of perineuronal oligodendrocytes (PNOGs) in the anterior horns. We performed a densitometry of myelin basic protein (MBP) immunoreactivity. The numbers of TDP-43 and p62 immunoreactive inclusions were counted in both the LCSs and the anterior horns. RESULTS: Double immunolabeling confirmed that oligodendrocytes harbor TDP-43 inclusions. In the LCSs, MBP density, but not the number of oligodendrocytes, was decreased in the diseased group. However, oligodendrocyte counts in the LCS correlated positively, and the density of MBP inversely, with the number of neuronal inclusions in the anterior horn, suggestive of a compensatory response of oligodendrocytes. The number of neurons with PNOGs correlated with the amount of inclusions. CONCLUSION: Our study further emphasizes the importance of oligodendroglia in the pathogenesis of TDP-43 proteinopathies with spinal cord involvement.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031911
003      
CZ-PrNML
005      
20181017145135.0
007      
ta
008      
151005s2014 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000362929 $2 doi
035    __
$a (PubMed)25115814
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Rohan, Zdeněk $u Department of Pathology and Molecular Medicine, Thomayer Hospital, Charles University in Prague, Prague, Czech Republic. $7 xx0230168
245    10
$a Oligodendroglial response in the spinal cord in TDP-43 proteinopathy with motor neuron involvement / $c Z. Rohan, R. Matej, R. Rusina, GG. Kovacs,
520    9_
$a BACKGROUND: TDP-43 proteinopathies represent a spectrum of neurodegenerative disorders. Variable clinical presentations including frontotemporal dementia, amyotrophic lateral sclerosis (ALS) and mixed forms are associated with the spatial heterogeneity of the TDP-43 pathology. Recent studies have emphasized the role of oligodendrocytes in the pathogenesis of ALS. OBJECTIVE: To evaluate whether TDP-43 proteinopathies are associated with an oligodendroglial response. METHODS: We performed a study on 7 controls and 10 diseased patients with spinal cord involvement. Using the oligodendroglia-specific antibody TPPP/p25, we assessed oligodendrocyte density in the lateral corticospinal tracts (LCSs) along with the presence of perineuronal oligodendrocytes (PNOGs) in the anterior horns. We performed a densitometry of myelin basic protein (MBP) immunoreactivity. The numbers of TDP-43 and p62 immunoreactive inclusions were counted in both the LCSs and the anterior horns. RESULTS: Double immunolabeling confirmed that oligodendrocytes harbor TDP-43 inclusions. In the LCSs, MBP density, but not the number of oligodendrocytes, was decreased in the diseased group. However, oligodendrocyte counts in the LCS correlated positively, and the density of MBP inversely, with the number of neuronal inclusions in the anterior horn, suggestive of a compensatory response of oligodendrocytes. The number of neurons with PNOGs correlated with the amount of inclusions. CONCLUSION: Our study further emphasizes the importance of oligodendroglia in the pathogenesis of TDP-43 proteinopathies with spinal cord involvement.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a buňky předních rohů míšních $x metabolismus $x patologie $7 D000870
650    _2
$a DNA vazebné proteiny $x metabolismus $7 D004268
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a buněčná inkluze $x metabolismus $x patologie $7 D002479
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a motorické neurony $x metabolismus $x patologie $7 D009046
650    _2
$a encefalitogenní základní proteiny $x metabolismus $7 D004676
650    _2
$a oligodendroglie $x metabolismus $x patologie $7 D009836
650    _2
$a pyramidové dráhy $x metabolismus $x patologie $7 D011712
650    _2
$a proteiny vázající RNA $x metabolismus $7 D016601
650    _2
$a mícha $x metabolismus $x patologie $7 D013116
650    _2
$a proteinopatie TDP-43 $x metabolismus $x patologie $7 D057177
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Matěj, Radoslav, $d 1974- $7 xx0103860
700    1_
$a Rusina, Robert, $d 1969- $7 mzk2007386024
700    1_
$a Kovacs, Gabor G
773    0_
$w MED00180453 $t Neuro-degenerative diseases $x 1660-2862 $g Roč. 14, č. 3 (2014), s. 117-124
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25115814 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20181017145634 $b ABA008
999    __
$a ok $b bmc $g 1092787 $s 915037
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 14 $c 3 $d 117-124 $e 20140805 $i 1660-2862 $m Neuro-degenerative diseases $n Neurodegener Dis $x MED00180453
GRA    __
$a NT12094 $p MZ0
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...